annual D&A:
$37.72M-$6.67M(-15.03%)Summary
- As of today (June 22, 2025), SRPT annual depreciation & amortization is $37.72 million, with the most recent change of -$6.67 million (-15.03%) on December 31, 2024.
- During the last 3 years, SRPT annual D&A has fallen by -$293.00 thousand (-0.77%).
- SRPT annual D&A is now -15.03% below its all-time high of $44.40 million, reached on December 31, 2023.
Performance
SRPT Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$9.98M-$477.00K(-4.56%)Summary
- As of today (June 22, 2025), SRPT quarterly depreciation & amortization is $9.98 million, with the most recent change of -$477.00 thousand (-4.56%) on March 1, 2025.
- Over the past year, SRPT quarterly D&A has increased by +$1.23 million (+14.11%).
- SRPT quarterly D&A is now -12.26% below its all-time high of $11.37 million, reached on December 31, 2023.
Performance
SRPT quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$38.96M+$1.23M(+3.27%)Summary
- As of today (June 22, 2025), SRPT TTM depreciation & amortization is $38.96 million, with the most recent change of +$1.23 million (+3.27%) on March 1, 2025.
- Over the past year, SRPT TTM D&A has dropped by -$2.88 million (-6.88%).
- SRPT TTM D&A is now -12.25% below its all-time high of $44.40 million, reached on December 31, 2023.
Performance
SRPT TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
SRPT Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -15.0% | +14.1% | -6.9% |
| 3 y3 years | -0.8% | -6.9% | -2.1% |
| 5 y5 years | +54.0% | +52.8% | +49.0% |
SRPT Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -15.0% | at low | -12.3% | +14.4% | -12.3% | +3.3% |
| 5 y | 5-year | -15.0% | +54.0% | -12.3% | +54.1% | -12.3% | +49.0% |
| alltime | all time | -15.0% | >+9999.0% | -12.3% | +2429.7% | -12.3% | >+9999.0% |
SRPT Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $9.98M(-4.6%) | $38.96M(+3.3%) |
| Dec 2024 | $37.72M(-15.0%) | $10.46M(+6.6%) | $37.72M(-2.4%) |
| Sep 2024 | - | $9.81M(+12.5%) | $38.64M(-2.8%) |
| Jun 2024 | - | $8.72M(-0.3%) | $39.76M(-5.0%) |
| Mar 2024 | - | $8.74M(-23.1%) | $41.84M(-5.8%) |
| Dec 2023 | $44.40M(+6.1%) | $11.37M(+4.1%) | $44.40M(+1.9%) |
| Sep 2023 | - | $10.93M(+1.3%) | $43.58M(+0.5%) |
| Jun 2023 | - | $10.79M(-4.5%) | $43.35M(+2.1%) |
| Mar 2023 | - | $11.30M(+7.1%) | $42.45M(+1.4%) |
| Dec 2022 | $41.86M(+10.1%) | $10.55M(-1.4%) | $41.86M(+1.0%) |
| Sep 2022 | - | $10.70M(+8.2%) | $41.46M(+0.5%) |
| Jun 2022 | - | $9.89M(-7.7%) | $41.25M(+3.6%) |
| Mar 2022 | - | $10.72M(+5.7%) | $39.81M(+4.7%) |
| Dec 2021 | $38.02M(+41.3%) | $10.14M(-3.3%) | $38.02M(+8.1%) |
| Sep 2021 | - | $10.49M(+24.2%) | $35.16M(+12.4%) |
| Jun 2021 | - | $8.45M(-5.4%) | $31.28M(+6.7%) |
| Mar 2021 | - | $8.93M(+22.5%) | $29.31M(+8.9%) |
| Dec 2020 | $26.91M(+9.8%) | $7.29M(+10.1%) | $26.91M(+2.4%) |
| Sep 2020 | - | $6.62M(+2.2%) | $26.27M(-0.5%) |
| Jun 2020 | - | $6.47M(-0.8%) | $26.39M(+0.9%) |
| Mar 2020 | - | $6.53M(-1.8%) | $26.15M(+6.7%) |
| Dec 2019 | $24.50M(+100.1%) | $6.65M(-1.4%) | $24.50M(+14.6%) |
| Sep 2019 | - | $6.74M(+8.1%) | $21.38M(+17.3%) |
| Jun 2019 | - | $6.23M(+27.8%) | $18.23M(+22.6%) |
| Mar 2019 | - | $4.88M(+38.3%) | $14.87M(+21.5%) |
| Dec 2018 | $12.24M(+51.3%) | $3.53M(-1.8%) | $12.24M(+12.9%) |
| Sep 2018 | - | $3.59M(+25.1%) | $10.84M(+10.5%) |
| Jun 2018 | - | $2.87M(+27.6%) | $9.81M(+12.6%) |
| Mar 2018 | - | $2.25M(+6.0%) | $8.71M(+7.6%) |
| Dec 2017 | $8.09M(+44.2%) | $2.12M(-17.0%) | $8.09M(+6.0%) |
| Sep 2017 | - | $2.56M(+44.4%) | $7.63M(+24.2%) |
| Jun 2017 | - | $1.77M(+8.2%) | $6.15M(+5.1%) |
| Mar 2017 | - | $1.64M(-1.6%) | $5.85M(+4.3%) |
| Dec 2016 | $5.61M(+6.9%) | $1.66M(+54.9%) | $5.61M(+5.6%) |
| Sep 2016 | - | $1.07M(-27.2%) | $5.31M(-4.3%) |
| Jun 2016 | - | $1.48M(+5.7%) | $5.55M(+3.4%) |
| Mar 2016 | - | $1.40M(+2.4%) | $5.36M(+2.2%) |
| Dec 2015 | $5.25M(+42.2%) | $1.36M(+4.0%) | $5.25M(+4.1%) |
| Sep 2015 | - | $1.31M(+1.6%) | $5.04M(+5.5%) |
| Jun 2015 | - | $1.29M(+0.9%) | $4.78M(+7.4%) |
| Mar 2015 | - | $1.28M(+10.5%) | $4.45M(+20.5%) |
| Dec 2014 | $3.69M(+189.0%) | $1.16M(+10.4%) | $3.69M(+31.3%) |
| Sep 2014 | - | $1.05M(+9.3%) | $2.81M(+37.2%) |
| Jun 2014 | - | $960.00K(+83.6%) | $2.05M(+51.9%) |
| Mar 2014 | - | $523.00K(+87.5%) | $1.35M(+5.6%) |
| Dec 2013 | $1.28M(-16.3%) | $279.00K(-2.8%) | $1.28M(-10.9%) |
| Sep 2013 | - | $287.00K(+10.4%) | $1.43M(-5.8%) |
| Jun 2013 | - | $260.00K(-42.4%) | $1.52M(-6.3%) |
| Mar 2013 | - | $451.00K(+3.7%) | $1.62M(+6.4%) |
| Dec 2012 | $1.52M(+17.3%) | $435.00K(+16.0%) | $1.52M(-6.3%) |
| Sep 2012 | - | $375.00K(+3.6%) | $1.63M(+6.7%) |
| Jun 2012 | - | $362.00K(+2.5%) | $1.52M(+7.9%) |
| Mar 2012 | - | $353.00K(-34.3%) | $1.41M(+8.8%) |
| Dec 2011 | $1.30M(-11.1%) | $537.00K(+96.7%) | $1.30M(+10.8%) |
| Sep 2011 | - | $273.00K(+8.8%) | $1.17M(-6.5%) |
| Jun 2011 | - | $251.00K(+5.0%) | $1.25M(-7.4%) |
| Mar 2011 | - | $239.00K(-41.7%) | $1.35M(-7.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2010 | $1.46M(+6.1%) | $410.00K(+15.5%) | $1.46M(+8.2%) |
| Sep 2010 | - | $355.00K(+1.1%) | $1.35M(-0.1%) |
| Jun 2010 | - | $351.00K(+1.2%) | $1.35M(-0.4%) |
| Mar 2010 | - | $347.00K(+16.1%) | $1.36M(-1.5%) |
| Dec 2009 | $1.38M(-6.1%) | $299.00K(-16.2%) | $1.38M(-8.4%) |
| Sep 2009 | - | $357.00K(+0.3%) | $1.51M(+0.7%) |
| Jun 2009 | - | $356.00K(-3.0%) | $1.50M(+0.5%) |
| Mar 2009 | - | $367.00K(-13.8%) | $1.49M(+1.2%) |
| Dec 2008 | $1.47M(-27.1%) | $425.60K(+22.9%) | $1.47M(-5.3%) |
| Sep 2008 | - | $346.40K(-0.5%) | $1.55M(-11.0%) |
| Jun 2008 | - | $348.00K(-0.3%) | $1.74M(-7.5%) |
| Mar 2008 | - | $349.00K(-31.2%) | $1.88M(-6.5%) |
| Dec 2007 | $2.01M(-3.7%) | $507.10K(-5.9%) | $2.01M(-1.1%) |
| Sep 2007 | - | $538.70K(+10.3%) | $2.04M(+0.8%) |
| Jun 2007 | - | $488.50K(+1.9%) | $2.02M(-1.2%) |
| Mar 2007 | - | $479.60K(-9.5%) | $2.04M(-2.2%) |
| Dec 2006 | $2.09M(+4.6%) | $529.70K(+1.3%) | $2.09M(-0.0%) |
| Sep 2006 | - | $522.70K(+1.9%) | $2.09M(+1.5%) |
| Jun 2006 | - | $512.80K(-2.3%) | $2.06M(+1.0%) |
| Mar 2006 | - | $525.10K(-0.9%) | $2.04M(+2.1%) |
| Dec 2005 | $2.00M(+5.8%) | $530.10K(+7.8%) | $2.00M(+0.6%) |
| Sep 2005 | - | $491.90K(+0.1%) | $1.99M(-30.6%) |
| Jun 2005 | - | $491.60K(+1.6%) | $2.86M(+47.3%) |
| Mar 2005 | - | $484.00K(-6.7%) | $1.94M(+3.0%) |
| Dec 2004 | $1.89M(+27.2%) | $518.60K(-62.1%) | $1.89M(+3.4%) |
| Sep 2004 | - | $1.37M(-419.7%) | $1.83M(+126.5%) |
| Jun 2004 | - | -$428.30K(-200.0%) | $805.90K(-49.0%) |
| Mar 2004 | - | $428.30K(-6.1%) | $1.58M(+6.4%) |
| Dec 2003 | $1.48M(+11.3%) | $456.20K(+30.5%) | $1.48M(+5.5%) |
| Sep 2003 | - | $349.70K(+1.3%) | $1.41M(+0.1%) |
| Jun 2003 | - | $345.30K(+3.6%) | $1.41M(+0.3%) |
| Mar 2003 | - | $333.20K(-12.1%) | $1.40M(+5.0%) |
| Dec 2002 | $1.33M(+139.6%) | $379.00K(+8.9%) | $1.33M(+12.0%) |
| Sep 2002 | - | $347.90K(+2.2%) | $1.19M(+24.1%) |
| Jun 2002 | - | $340.40K(+28.0%) | $959.90K(+31.6%) |
| Mar 2002 | - | $266.00K(+12.5%) | $729.40K(+31.1%) |
| Dec 2001 | $556.50K(+33.6%) | $236.50K(+102.1%) | $556.50K(+11.0%) |
| Sep 2001 | - | $117.00K(+6.5%) | $501.30K(+6.5%) |
| Jun 2001 | - | $109.90K(+18.0%) | $470.80K(+7.8%) |
| Mar 2001 | - | $93.10K(-48.6%) | $436.90K(+4.9%) |
| Dec 2000 | $416.50K(+38.8%) | $181.30K(+109.6%) | $416.50K(+24.3%) |
| Sep 2000 | - | $86.50K(+13.8%) | $335.20K(-3.9%) |
| Jun 2000 | - | $76.00K(+4.5%) | $348.70K(+27.9%) |
| Mar 2000 | - | $72.70K(-27.3%) | $272.70K(-9.1%) |
| Dec 1999 | $300.00K(+50.0%) | $100.00K(0.0%) | $300.00K(+50.0%) |
| Sep 1999 | - | $100.00K(>+9900.0%) | $200.00K(0.0%) |
| Jun 1999 | - | $0.00(-100.0%) | $200.00K(0.0%) |
| Mar 1999 | - | $100.00K(>+9900.0%) | $200.00K(0.0%) |
| Dec 1998 | $200.00K(-60.0%) | $0.00(-100.0%) | $200.00K(-50.0%) |
| Sep 1998 | - | $100.00K(>+9900.0%) | $400.00K(+33.3%) |
| Jun 1998 | - | $0.00(-100.0%) | $300.00K(-40.0%) |
| Mar 1998 | - | $100.00K(-50.0%) | $500.00K(0.0%) |
| Dec 1997 | $500.00K(0.0%) | $200.00K(>+9900.0%) | $500.00K(+66.7%) |
| Sep 1997 | - | $0.00(-100.0%) | $300.00K(0.0%) |
| Jun 1997 | - | $200.00K(+100.0%) | $300.00K(+200.0%) |
| Mar 1997 | - | $100.00K | $100.00K |
| Dec 1996 | $500.00K | - | - |
FAQ
- What is Sarepta Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Sarepta Therapeutics?
- What is Sarepta Therapeutics annual D&A year-on-year change?
- What is Sarepta Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly D&A year-on-year change?
- What is Sarepta Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Sarepta Therapeutics?
- What is Sarepta Therapeutics TTM D&A year-on-year change?
What is Sarepta Therapeutics annual depreciation & amortization?
The current annual D&A of SRPT is $37.72M
What is the all time high annual D&A for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual depreciation & amortization is $44.40M
What is Sarepta Therapeutics annual D&A year-on-year change?
Over the past year, SRPT annual depreciation & amortization has changed by -$6.67M (-15.03%)
What is Sarepta Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of SRPT is $9.98M
What is the all time high quarterly D&A for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly depreciation & amortization is $11.37M
What is Sarepta Therapeutics quarterly D&A year-on-year change?
Over the past year, SRPT quarterly depreciation & amortization has changed by +$1.23M (+14.11%)
What is Sarepta Therapeutics TTM depreciation & amortization?
The current TTM D&A of SRPT is $38.96M
What is the all time high TTM D&A for Sarepta Therapeutics?
Sarepta Therapeutics all-time high TTM depreciation & amortization is $44.40M
What is Sarepta Therapeutics TTM D&A year-on-year change?
Over the past year, SRPT TTM depreciation & amortization has changed by -$2.88M (-6.88%)